Upper GI and hepatobiliary cancers

Warning

This document sets out the current referral guidelines and pathways for the management of patients referred with a suspicion of Oesophago-Gastric (Upper GI) or Hepatobiliary (HPB) cancer, including highlighting which elements of the pathway will be provided locally by NHS Borders, and which will require to be undertaken in NHS Lothian (Tertiary services).

The Upper GI and HPB cancer service is provided by:

  • Dr Jonathan Fletcher, Consultant Gastroenterologist and Oesophago-Gastric Tumour Site Lead
  • Dr Jonathan Manning, Clinical Director and Consultant Gastroenterologist
  • Mr Jamie Young, Consultant General Surgeon and Hepatobiliary Tumour Site Lead
  • Louise Horne, Endoscopy Senior Charge Nurse
  • Rachel Johnson, Clinical Nurse Specialist
  • Rebecca Bell, Clinical Nurse Specialist

Patients referred as Urgent with Suspicion of Cancer will be tracked against either the Upper GI or HPB pathways, depending on how their condition was diagnosed.

Upper gastrointestinal (GI) cancer is an umbrella term for multiple different cancer types, including oesophageal, stomach, pancreatic, gallbladder and liver.

Upper GI cancers (excluding gallbladder due to data availability) accounted for around 9% of new cancer cases in Scotland in 2021 and 2022 (excluding non-melanoma skin cancer). Late stage diagnosis is common for upper GI cancers, with 25.0% of liver, 40.6% of stomach, 35.3% of oesophageal and 53.1% of pancreatic cancers being diagnosed at stage 4 in Scotland in 2021.Upper GI cancers (where incidence data is available in Scotland) have a higher incidence in those from more deprived areas.

Oesophago-gastric (OG) cancer:

UK data (2017-2019) indicates the following risk factors:

  • Increasing age (it is less likely under the age of 40)
  • Two times greater risk in men than women
  • Family history of OG cancer
  • Lower socioeconomic status
  • Smoking
  • Excessive alcohol use
  • Chronic gastro-oesophageal reflux
  • Barrett's oesophagus
  • Obesity (e.g. greater than two-fold higher risk of oesophageal cancer if BMI greater than 30 compared with Body Mass Index (BMI) less than 25)
  • Prior history of aero-digestive cancers

Hepato-pancreato-biliary (HPB) cancer:

Pancreatic cancer is less likely below the age of 40 with incidence rates rising steeply from age 60. Risk factors include:

  • Smoking
  • Excessive alcohol use
  • Chronic pancreatitis
  • Family history
  • Liver cancer is less common than pancreatic cancer1. Risk factors include74:
  • Smoking
  • Obesity
  • Excessive alcohol use
  • Chronic liver disease
  • Viral hepatitis
  • Haemachromatosis
  • Family history of liver cancer

Who to refer, who not to refer, how to refer

Upper GI & HPB Cancer: Hepatobiliary & Pancreatic Urgent Suspicion of Cancer Referral Criteria

Hepato-pancreato-biliary (HPB) cancer:

Pancreatic cancer is less likely below the age of 40 with incidence rates rising steeply from age 60. Risk factors include:

  • Smoking
  • Excessive alcohol use
  • Chronic pancreatitis
  • Family history
  • Liver cancer is less common than pancreatic cancer1. Risk factors include74:
  • Smoking
  • Obesity
  • Excessive alcohol use
  • Chronic liver disease
  • Viral hepatitis
  • Haemachromatosis
  • Family history of liver cancer

Good Practice Points

  • Consider seeking advice in people presenting with new onset GI symptoms with known chronic liver disease Symptoms and signs of oesophago-gastric and hepatobiliary and pancreatic cancers overlap to a large extent. This table summarises examples of symptoms and signs that can be associated with the different cancers – they are NOT by themselves necessarily reasons to refer.

 

Associated symptoms/signs Pancreas, liver and gall bladder cancer Oesophagogastric cancer
Dysphagia  
Iron deficiency anaemia  
Haematemesis  
Reflux symptoms  
Vomiting (>two weeks)
Upper abdominal pain
Unexplained weight loss
Upper abdominal mass
Post-prandial pain
Early satiety (feeling full up after a small amount of food)
Unexplained obstructive jaundice  
Unexplained back pain  
Late onset diabetes  
New onset IBS >40 years  
Steatorrhoea or malabsorption  

Upper GI & HPB Cancer: Upper GI Urgent Suspicion of Cancer Referral Criteria

Referral guidance:

Referral to secondary care for USC assessment will vary by Health Board – please follow the local pathway.

Referrals will be triaged by secondary care clinicians. It is therefore important that when a person is referred, they are advised they are being referred for assessment, not for a specific investigation (e.g. an endoscopy).

When making a referral for a person with dysphagia it is essential that the correct information is included in the referral form to allow the secondary care team to triage the referral. Please see CfSD’s Dysphagia pathway for guidance.

Overlap with other pathways:

Patients with intra-abdominal cancer can present with symptoms that overlap. Please see Lower GI cancer guidelineOvarian cancer guideline and Kidney cancer guideline.

A normal Oesophago-Gastro-Duodenoscopy (OGD) or CT alone may be insufficient to exclude an upper GI cancer. Consideration should be given to using both modalities where clinically indicated, depending on symptoms, age, sex and risk factors.

There may also be a role for referral to a local pathway for non-specific symptoms in which cancer is suspected such as GP direct access to CT or to a RCDS. See also the Non-specific symptoms of cancer guideline.

Iron deficiency anaemia (IDA) falls below the 3% threshold for upper GI cancer and is therefore not included in the above USC referral criteria. See Lower gastrointestinal cancer guideline for initial investigation.

Thrombocytosis:

Evidence has identified thrombocytosis as a risk marker for malignancy. In cases of unexplained thrombocytosis, it is advisable to assess for any signs or symptoms of cancer and if appropriate refer to a tumour specific USC pathway. Please see the section on thrombocytosis in Referral process/Further considerations for assessment and referral.

Primary care management

Primary Care Management Dyspepsia without accompanying symptoms or risk factors should be managed in Primary Care

Consider routine referral for people presenting with new upper gastrointestinal pain or discomfort combined with any of the following risk factors:

  • family history of oesophago-gastric cancer in a first-degree relative
  • Barrett’s oesophagus
  • pernicious anaemia
  • previous gastric surgery
  • achalasia (dysfunction of the oesophageal muscle)
  • known dysplasia, atrophic gastritis or intestinal metaplasia

Editorial Information

Last reviewed: 01/12/2025

Next review date: 01/12/2028